These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 38097907)

  • 1. Biofilm formation: mechanistic insights and therapeutic targets.
    Wang X; Liu M; Yu C; Li J; Zhou X
    Mol Biomed; 2023 Dec; 4(1):49. PubMed ID: 38097907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Antibiofilm Therapeutics Strategies to Overcome Antimicrobial Drug Resistance.
    Nadar S; Khan T; Patching SG; Omri A
    Microorganisms; 2022 Jan; 10(2):. PubMed ID: 35208758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three lines of defense: A multifunctional coating with anti-adhesion, bacteria-killing and anti-quorum sensing properties for preventing biofilm formation of Pseudomonas aeruginosa.
    Zou Y; Liu C; Zhang H; Wu Y; Lin Y; Cheng J; Lu K; Li L; Zhang Y; Chen H; Yu Q
    Acta Biomater; 2022 Oct; 151():254-263. PubMed ID: 35961522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving biofilm inhibition and eradication in clinical settings through plant-based antibiofilm agents.
    Silva E; Teixeira JA; Pereira MO; Rocha CMR; Sousa AM
    Phytomedicine; 2023 Oct; 119():154973. PubMed ID: 37499434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Potential Antimicrobial Targets of Pseudomonas aeruginosa Biofilms through a Novel Screening Approach.
    Valentin JDP; Altenried S; Varadarajan AR; Ahrens CH; Schreiber F; Webb JS; van der Mei HC; Ren Q
    Microbiol Spectr; 2023 Feb; 11(2):e0309922. PubMed ID: 36779712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent perspectives on the molecular basis of biofilm formation by Pseudomonas aeruginosa and approaches for treatment and biofilm dispersal.
    Skariyachan S; Sridhar VS; Packirisamy S; Kumargowda ST; Challapilli SB
    Folia Microbiol (Praha); 2018 Jul; 63(4):413-432. PubMed ID: 29352409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combating Bacterial Biofilms: Current and Emerging Antibiofilm Strategies for Treating Persistent Infections.
    Abdelhamid AG; Yousef AE
    Antibiotics (Basel); 2023 Jun; 12(6):. PubMed ID: 37370324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of
    Yin R; Cheng J; Wang J; Li P; Lin J
    Front Microbiol; 2022; 13():955286. PubMed ID: 36090087
    [No Abstract]   [Full Text] [Related]  

  • 9. Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities.
    Tolker-Nielsen T
    APMIS Suppl; 2014 Dec; (138):1-51. PubMed ID: 25399808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Iron uptake and biofilm formation in Pseudomonas aeruginosa].
    Yu S; Ma L
    Sheng Wu Gong Cheng Xue Bao; 2017 Sep; 33(9):1489-1512. PubMed ID: 28956396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motility-Independent Formation of Antibiotic-Tolerant Pseudomonas aeruginosa Aggregates.
    Demirdjian S; Sanchez H; Hopkins D; Berwin B
    Appl Environ Microbiol; 2019 Jul; 85(14):. PubMed ID: 31076438
    [No Abstract]   [Full Text] [Related]  

  • 12. Understanding the intricacies of microbial biofilm formation and its endurance in chronic infections: a key to advancing biofilm-targeted therapeutic strategies.
    Dsouza FP; Dinesh S; Sharma S
    Arch Microbiol; 2024 Feb; 206(2):85. PubMed ID: 38300317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action.
    Roy R; Tiwari M; Donelli G; Tiwari V
    Virulence; 2018 Jan; 9(1):522-554. PubMed ID: 28362216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biofilm Maintenance as an Active Process: Evidence that Biofilms Work Hard to Stay Put.
    Katharios-Lanwermeyer S; O'Toole GA
    J Bacteriol; 2022 Apr; 204(4):e0058721. PubMed ID: 35311557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms and Control Strategies of Antibiotic Resistance in Pathological Biofilms.
    Luo Y; Yang Q; Zhang D; Yan W
    J Microbiol Biotechnol; 2021 Jan; 31(1):1-7. PubMed ID: 33323672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipathogenic Compounds That Are Effective at Very Low Concentrations and Have Both Antibiofilm and Antivirulence Effects against Pseudomonas aeruginosa.
    Hwang HJ; Choi H; Hong S; Moon HR; Lee JH
    Microbiol Spectr; 2021 Oct; 9(2):e0024921. PubMed ID: 34494853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-Functional Surfaces Based on an Antifouling Polymer and a Natural Antibiofilm Molecule: Prevention of Biofilm Formation without Using Biocides.
    Zou Y; Lu K; Lin Y; Wu Y; Wang Y; Li L; Huang C; Zhang Y; Brash JL; Chen H; Yu Q
    ACS Appl Mater Interfaces; 2021 Sep; 13(38):45191-45200. PubMed ID: 34519474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic resistance in Pseudomonas aeruginosa biofilms: towards the development of novel anti-biofilm therapies.
    Taylor PK; Yeung AT; Hancock RE
    J Biotechnol; 2014 Dec; 191():121-30. PubMed ID: 25240440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the Holy Triangle of Quorum Sensing, Biofilm Formation, and Antibiotic Resistance in Pathogenic Bacteria.
    Sionov RV; Steinberg D
    Microorganisms; 2022 Jun; 10(6):. PubMed ID: 35744757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Pseudomonas aeruginosa use intercellular signalling to build biofilm communities?
    Kirisits MJ; Parsek MR
    Cell Microbiol; 2006 Dec; 8(12):1841-9. PubMed ID: 17026480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.